VeriMom¿Es dibromopropamidine diisethionate seguro durante el embarazo?
No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.
Related ingredients
Frequently asked questions
- ¿Es dibromopropamidine diisethionate seguro durante el embarazo?
- No harmonised CLP classification or SCCS/CIR safety assessment was found for dibromopropamidine diisethionate (CAS 614-87-9); no reproductive or developmental toxicity studies for this substance were located in PubMed. The substance is used topically (ophthalmic/antiseptic formulations at ~0.15%), so systemic exposure from typical topical/ophthalmic use is expected to be low but measurable. Sources: ECHA substance page, PubChem, product/pharmacopoeia listings showing topical/ophthalmic use.
- ¿Es dibromopropamidine diisethionate seguro durante la lactancia?
- No evidence of reproductive or developmental hazard or mechanism specific to this compound was found. Because topical/ophthalmic use leads to low but measurable systemic exposure, a low exposure score is assigned for lactation; no data on milk transfer were located. Sources: PubChem entry, product/labeling references indicating topical ophthalmic use; no PubMed studies on lactation or milk transfer were found.
- ¿Es dibromopropamidine diisethionate seguro para la piel del bebé?
- No infant-specific reproductive or mechanistic evidence was found. The ingredient is used in topical/ophthalmic products (including products for children in some markets), and immature infant skin has higher per‑kg exposure; therefore exposure is scored one category higher than adult topical use. No data were found showing increased hazard or specific infant toxicity. Sources: product/medicinal listings showing pediatric topical/ophthalmic use and pharmacopoeial references; absence of reproductive/toxicity studies in PubMed.
- ¿Cómo puntúa VeriMom a dibromopropamidine diisethionate?
- VeriMom puntúa dibromopropamidine diisethionate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a dibromopropamidine diisethionate en el embarazo?
- Consulta nuestra lista de alternativas seguras a dibromopropamidine diisethionate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.